Everyone wants to keep Medicare on solid financial footing. But getting agreement on how to go about it is a challenge, especially with power divided in Washington. Several drugmakers have now filed lawsuits against the Department of Health and Human Services over Medicare's new authority to negotiate drug prices in the Inflation Reduction Act.
Continue Reading
